{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["acetylcholinesterase", "ceanothic acid", "pentacyclic triterpenes"]], "OtherAbstract": [], "SpaceFlightMission": [], "InvestigatorList": [], "CitationSubset": ["IM"], "OtherID": [], "GeneralNote": [], "PMID": "39000410", "DateCompleted": {"Year": "2024", "Month": "07", "Day": "13"}, "DateRevised": {"Year": "2024", "Month": "07", "Day": "15"}, "Article": {"Language": ["eng"], "ELocationID": ["7303", "10.3390/ijms25137303"], "ArticleDate": [{"Year": "2024", "Month": "07", "Day": "03"}], "Journal": {"ISSN": "1422-0067", "JournalIssue": {"Volume": "25", "Issue": "13", "PubDate": {"Year": "2024", "Month": "Jul", "Day": "03"}}, "Title": "International journal of molecular sciences", "ISOAbbreviation": "Int J Mol Sci"}, "ArticleTitle": "Ceanothanes Derivatives as Peripheric Anionic Site and Catalytic Active Site Inhibitors of Acetylcholinesterase: Insights for Future Drug Design.", "Abstract": {"AbstractText": ["Alzheimer's disease (AD) is a multifactorial and fatal neurodegenerative disorder. Acetylcholinesterase (AChE) plays a key role in the regulation of the cholinergic system and particularly in the formation of amyloid plaques; therefore, the inhibition of AChE has become one of the most promising strategies for the treatment of AD, particularly concerning AChE inhibitors that interact with the peripheral anionic site (PAS). Ceanothic acid isolated from the Chilean Rhamnaceae plants is an inhibitor of AChE through its interaction with PAS. In this study, six ceanothic acid derivatives were prepared, and all showed inhibitory activity against AChE. The structural modifications were performed starting from ceanothic acid by application of simple synthetic routes: esterification, reduction, and oxidation. AChE activity was determined by the Ellmann method for all compounds. Kinetic studies indicated that its inhibition was competitive and reversible. According to the molecular coupling and displacement studies of the propidium iodide test, the inhibitory effect of compounds would be produced by interaction with the PAS of AChE. In silico predictions of physicochemical properties, pharmacokinetics, drug-likeness, and medicinal chemistry friendliness of the ceanothane derivatives were performed using the Swiss ADME tool."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Grupo de Investigaci\u00f3n Qu\u00edmica y Biotecnolog\u00eda de Productos Naturales Bioactivos, Laboratorio de S\u00edntesis y Biotransformaci\u00f3n de Productos Naturales, Departamento de Ciencias B\u00e1sicas, Facultad de Ciencias, Universidad del B\u00edo-B\u00edo, Chill\u00e1n 3800708, Chile."}], "LastName": "Pastene-Burgos", "ForeName": "Sof\u00eda", "Initials": "S"}, {"Identifier": ["0000-0002-4844-2137"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Grupo de Investigaci\u00f3n Qu\u00edmica y Biotecnolog\u00eda de Productos Naturales Bioactivos, Laboratorio de S\u00edntesis y Biotransformaci\u00f3n de Productos Naturales, Departamento de Ciencias B\u00e1sicas, Facultad de Ciencias, Universidad del B\u00edo-B\u00edo, Chill\u00e1n 3800708, Chile."}], "LastName": "Mu\u00f1oz-Nu\u00f1ez", "ForeName": "Evelyn", "Initials": "E"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Grupo de Investigaci\u00f3n Qu\u00edmica y Biotecnolog\u00eda de Productos Naturales Bioactivos, Laboratorio de S\u00edntesis y Biotransformaci\u00f3n de Productos Naturales, Departamento de Ciencias B\u00e1sicas, Facultad de Ciencias, Universidad del B\u00edo-B\u00edo, Chill\u00e1n 3800708, Chile."}], "LastName": "Quiroz-Carre\u00f1o", "ForeName": "Soledad", "Initials": "S"}, {"Identifier": ["0000-0001-5437-9210"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Grupo de Investigaci\u00f3n Qu\u00edmica y Biotecnolog\u00eda de Productos Naturales Bioactivos, Laboratorio de S\u00edntesis y Biotransformaci\u00f3n de Productos Naturales, Departamento de Ciencias B\u00e1sicas, Facultad de Ciencias, Universidad del B\u00edo-B\u00edo, Chill\u00e1n 3800708, Chile."}], "LastName": "Pastene-Navarrete", "ForeName": "Edgar", "Initials": "E"}, {"Identifier": ["0000-0002-4054-7487"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Departamento de Qu\u00edmica, Universidad Federico Santa Mar\u00eda, Valpara\u00edso 2340000, Chile."}], "LastName": "Espinoza Catalan", "ForeName": "Luis", "Initials": "L"}, {"Identifier": ["0000-0001-5077-474X"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Departamento An\u00e1lisis Instrumental, Facultad de Farmacia, Universidad de Concepci\u00f3n, Concepci\u00f3n 4030000, Chile."}], "LastName": "Bustamante", "ForeName": "Luis", "Initials": "L"}, {"Identifier": ["0000-0001-7473-8823"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Grupo de Investigaci\u00f3n Qu\u00edmica y Biotecnolog\u00eda de Productos Naturales Bioactivos, Laboratorio de S\u00edntesis y Biotransformaci\u00f3n de Productos Naturales, Departamento de Ciencias B\u00e1sicas, Facultad de Ciencias, Universidad del B\u00edo-B\u00edo, Chill\u00e1n 3800708, Chile."}], "LastName": "Alarc\u00f3n-Enos", "ForeName": "Julio", "Initials": "J"}], "GrantList": [{"GrantID": "Fondecyt 1210673", "Agency": "Agencia Nacional de Investigaci\u00f3n y Desarrollo", "Country": ""}, {"GrantID": "Fondecyt N\u00b0 1161157", "Agency": "Agencia Nacional de Investigaci\u00f3n y Desarrollo", "Country": ""}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Int J Mol Sci", "NlmUniqueID": "101092791", "ISSNLinking": "1422-0067"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Cholinesterase Inhibitors"}, {"RegistryNumber": "EC 3.1.1.7", "NameOfSubstance": "Acetylcholinesterase"}, {"RegistryNumber": "0", "NameOfSubstance": "Anions"}], "MeshHeadingList": [{"QualifierName": ["chemistry", "pharmacology"], "DescriptorName": "Cholinesterase Inhibitors"}, {"QualifierName": ["chemistry", "metabolism"], "DescriptorName": "Acetylcholinesterase"}, {"QualifierName": [], "DescriptorName": "Catalytic Domain"}, {"QualifierName": [], "DescriptorName": "Drug Design"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["drug therapy"], "DescriptorName": "Alzheimer Disease"}, {"QualifierName": [], "DescriptorName": "Kinetics"}, {"QualifierName": [], "DescriptorName": "Molecular Docking Simulation"}, {"QualifierName": [], "DescriptorName": "Structure-Activity Relationship"}, {"QualifierName": ["chemistry"], "DescriptorName": "Anions"}, {"QualifierName": [], "DescriptorName": "Animals"}], "CoiStatement": "The authors declare no conflicts of interest."}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Leon R., Garcia A.G., Marco-Contelles J. Recent advances in the multitarget-directed ligands approach for the treatment of Alzheimer\u2019s disease. Med. Res. Res. Rev. 2013;33:139\u2013189. doi: 10.1002/med.20248.", "ArticleIdList": ["10.1002/med.20248", "21793014"]}, {"Citation": "Savelieff M.G., Nam G., Kang J., Lee H.J., Lee M., Lim M.H. Development of Multifunctional Molecules as Potential Therapeutic Candidates for Alzheimer\u2019s Disease, Parkinson\u2019s Disease, and Amyotrophic Lateral Sclerosis in the Last Decade. Chem. Rev. 2019;119:1221\u20131322. doi: 10.1021/acs.chemrev.8b00138.", "ArticleIdList": ["10.1021/acs.chemrev.8b00138", "30095897"]}, {"Citation": "Bortolami M., Rocco D., Messore A., Di Santo R., Costi R., Madia V.N., Scipione L., Pandolfi F. Acetylcholinesterase inhibitors for the treatment of Alzheimer\u2019s disease\u2014A patent review (2016\u2013present) Expert Opin. Ther. Pat. 2021;31:399\u2013420. doi: 10.1080/13543776.2021.1874344.", "ArticleIdList": ["10.1080/13543776.2021.1874344", "33428491"]}, {"Citation": "Cummings J., Lee G., Ritter A., Sabbagh M., Zhong K. Alzheimer\u2019s disease drug development pipeline: 2020. Alzheimers Dement. 2020;6:e12050. doi: 10.1002/trc2.12050.", "ArticleIdList": ["10.1002/trc2.12050", "PMC7364858", "32695874"]}, {"Citation": "Martin J.B. Molecular basis of the neurodegenerative disorders. N. Engl. J. Med. 1999;340:1970\u20131980. doi: 10.1056/NEJM199906243402507.", "ArticleIdList": ["10.1056/NEJM199906243402507", "10379022"]}, {"Citation": "Mattson M.P. Apoptosis in neurodegenerative disorders. Nat. Rev. Mol. Cell Biol. 2000;1:120\u2013130. doi: 10.1038/35040009.", "ArticleIdList": ["10.1038/35040009", "11253364"]}, {"Citation": "Querfurth H.W., La Ferla F.M. Mechanisms of disease: Alzheimer\u2019s Disease. N. Engl. J. Med. 2020;362:329\u2013344. doi: 10.1056/NEJMra0909142.", "ArticleIdList": ["10.1056/NEJMra0909142", "20107219"]}, {"Citation": "Devenish S.R.A. The current landscape in Alzheimer\u2019s disease research and drug discovery. Drug Discov. Today. 2020;25:943\u2013945. doi: 10.1016/j.drudis.2020.04.002.", "ArticleIdList": ["10.1016/j.drudis.2020.04.002", "32360713"]}, {"Citation": "Huang W.J., Zhang X., Chen W.W. Role of oxidative stress in Alzheimer\u2019s disease. Biomed. Rep. 2016;4:519\u2013522. doi: 10.3892/br.2016.630.", "ArticleIdList": ["10.3892/br.2016.630", "PMC4840676", "27123241"]}, {"Citation": "De Leo G., Gulino R., Coradazzi M., Leanza G. Acetylcholine and noradrenaline differentially regulate hippocampus-dependent spatial learning and memory. Brain Commun. 2023;5:fcac338. doi: 10.1093/braincomms/fcac338.", "ArticleIdList": ["10.1093/braincomms/fcac338", "PMC9825812", "36632183"]}, {"Citation": "Mucke L. Alzheimer\u2019s disease. Nature. 2009;461:895\u2013897. doi: 10.1038/461895a.", "ArticleIdList": ["10.1038/461895a", "19829367"]}, {"Citation": "Chen Z.R., Huang J.B., Yang S.L., Hong F.F. Role of Cholinergic Signaling in Alzheimer\u2019s Disease. Molecules. 2022;27:1816. doi: 10.3390/molecules27061816.", "ArticleIdList": ["10.3390/molecules27061816", "PMC8949236", "35335180"]}, {"Citation": "Feld G.B., Born J. Neurochemical mechanisms for memory processing during sleep: Basic findings in humans and neuropsychiatric implications. Neuropsychopharmacology. 2020;45:31\u201344. doi: 10.1038/s41386-019-0490-9.", "ArticleIdList": ["10.1038/s41386-019-0490-9", "PMC6879745", "31443105"]}, {"Citation": "Orta-Salazar E., Cuellar-Lemus C.A., D\u00edaz-Cintra S., Feria-Velasco A.I. Cholinergic markers in the cortex and hippocampus of some animal species and their correlation to Alzheimer\u2019s disease. Neurol Engl. 2014;29:497\u2013503. doi: 10.1016/j.nrleng.2012.10.010.", "ArticleIdList": ["10.1016/j.nrleng.2012.10.010", "23433740"]}, {"Citation": "Rees T.M., Berson A., Sklan E.H., Younkin S., Brimijoin S., Soreq H. Memory deficits correlating with acetylcholinesterase splice shift and amyloid burden in doubly transgenic mice. Curr. Alzheimer\u2019s Res. 2005;2:291\u2013300. doi: 10.2174/1567205054367847.", "ArticleIdList": ["10.2174/1567205054367847", "15974894"]}, {"Citation": "Bartolini M., Bertucci C., Cavrini V., Andrisano V. \u03b2-Amyloid aggregation induced by human acetylcholinesterase: Inhibition studies. Biochem. Pharmacol. 2003;65:407\u2013416. doi: 10.1016/S0006-2952(02)01514-9.", "ArticleIdList": ["10.1016/S0006-2952(02)01514-9", "12527333"]}, {"Citation": "Inestrosa N.C., Dinamarca M.C., Alvarez A. Amyloid-cholinesterase interaction implications for Alzheimer\u2019s disease. FEBS J. 2008;275:625\u2013632. doi: 10.1111/j.1742-4658.2007.06238.x.", "ArticleIdList": ["10.1111/j.1742-4658.2007.06238.x", "18205831"]}, {"Citation": "Carvajal F.J., Inestrosa N.C. Interactions of AChE with A\u03b2 Aggregates in Alzheimer\u2019s Brain: Therapeutic Relevance of IDN 5706. Front. Mol. Neurosci. 2011;4:19. doi: 10.3389/fnmol.2011.00019.", "ArticleIdList": ["10.3389/fnmol.2011.00019", "PMC3172730", "21949501"]}, {"Citation": "Racchi M., Mazzucchelli M., Porrello E., Lanni C., Govoni S. Acetylcholinesterase inhibitor: Novel activities of old molecules. Pharmacol. Res. 2004;50:441\u2013451. doi: 10.1016/j.phrs.2003.12.027.", "ArticleIdList": ["10.1016/j.phrs.2003.12.027", "15304241"]}, {"Citation": "Martinez A., Castro A. Novel cholinesterase inhibitors as future affective drugs for the treatment of Alzheimer\u2019s disease. Experr. Opin. Ivestig. Drugs. 2006;15:1\u201312. doi: 10.1517/13543784.15.1.1.", "ArticleIdList": ["10.1517/13543784.15.1.1", "16370929"]}, {"Citation": "Murphy M.P., LeVine H. Alzheimer\u2019s and the \u03b2-Amyloid peptide. J. Alzheimer\u2019s. 2010;19:311\u2013328. doi: 10.3233/JAD-2010-1221.", "ArticleIdList": ["10.3233/JAD-2010-1221", "PMC2813509", "20061647"]}, {"Citation": "Hurtado-Puerto A.M., Russo C., Fregni F. Alzheimer\u2019s Disease: Cellular and Molecular Aspects of Amyloid Beta. Springer US; Berlin/Heidelberg, Germany: 2005. Springer US 38."}, {"Citation": "Chierrito T.P., Pedersoli-Mantoani S., Roca C., Requena C., Sebastian-Perez V., Castillo W.O., Moreira N.C., P\u00e9rez C., Sakamoto-Hojo E.T., Takahashi C.S., et al. From dual binding site acetylcholinesterase inhibitors to allosteric modulators: A new avenue for disease modifying drugs in Alzheimer\u2019s disease. Eur. J. Med. Chem. 2017;139:773\u2013791. doi: 10.1016/j.ejmech.2017.08.051.", "ArticleIdList": ["10.1016/j.ejmech.2017.08.051", "28863358"]}, {"Citation": "Pourshojaei Y., Abiri1 A., Eskandari K., Haghighijoo Z., Edraki N., Asadipour A. Phenoxyethyl Piperidine/Morpholine derivatives as PAS and CAS inhibitors of Cholinesterases: Insights for future drug design. Sci. Rep. 2019;9:19855. doi: 10.1038/s41598-019-56463-2.", "ArticleIdList": ["10.1038/s41598-019-56463-2", "PMC6934599", "31882733"]}, {"Citation": "Lushchekina S.V., Kots E.D., Novichkova D.A., Petrov K.A., Masson P. Role of Acetylcholinesterase in -Amyloid Aggregation Studied by Accelerated Molecular Dynamics. BioNanoScience. 2017;7:396\u2013402. doi: 10.1007/s12668-016-0375-x.", "ArticleIdList": ["10.1007/s12668-016-0375-x"]}, {"Citation": "Inestrosa N.C., Alvarez A., P\u00e9rez C.A., Moreno R.D., Vicente M., Linker C., Casanueva O.I., Soto C., Garrido J. Acetylcholinesterase Accelerates Assembly of Amyloid--Peptides into Alzheimer\u2019s Fibrils: Possible Role of the Peripheral Site of the Enzyme. Neuron. 1996;16:881\u2013891. doi: 10.1016/S0896-6273(00)80108-7.", "ArticleIdList": ["10.1016/S0896-6273(00)80108-7", "8608006"]}, {"Citation": "Quiroz S., Cespedes C.L., Alderete J.B., Alarc\u00f3n J. Ceanothane and oleanane-type triterpenes from Talguenea quinquenervia have insecticidal activity against Cydia pomonella, Tenebrio molitor and Drosophila melanogaster. Ind. Crops Prod. 2015;74:759\u2013766. doi: 10.1016/j.indcrop.2015.06.003.", "ArticleIdList": ["10.1016/j.indcrop.2015.06.003"]}, {"Citation": "Mu\u00f1oz-Nu\u00f1ez E., Quiroz-Carre\u00f1o S., Pastene-Navarrete E., Seigler D.S., Cespedes-Acu\u00f1a C., Martinez I., Opplinger M., Salas-Burgos A., Alarc\u00f3n-Enos J. Assessments of Ceanothanes Triterpenes as Cholinesterase Inhibitors: An Investigation of Potential Agents with Novel Inspiration for Drug Treatment of Neurodegenerative Diseases. Molecules. 2022;12:668. doi: 10.3390/metabo12070668.", "ArticleIdList": ["10.3390/metabo12070668", "PMC9318782", "35888792"]}, {"Citation": "De Ferrari G.V., Canales M.A., Shin I., Weiner L.M., Silman I., Inestrosa N.C. A structural motif of acetylcholinesterase that promotes amyloid beta-peptide fibril formation. Biochemistry. 2001;40:10447\u201310457. doi: 10.1021/bi0101392.", "ArticleIdList": ["10.1021/bi0101392", "11523986"]}, {"Citation": "Taylor P., Lappi S. Interaction of fluorescence probes with acetylcholinesterase. Site and specificity of propidium binding. Biochemistry. 1975;14:1989\u20131997. doi: 10.1021/bi00680a029.", "ArticleIdList": ["10.1021/bi00680a029", "1125207"]}, {"Citation": "Tripathi A., Choubey P.K., Sharma P., Seth A., Tripathi P.N., Tripathi M.K., Prajapati S.K., Krishnamurthy S., Shrivastava S.K. Design and development of molecular hybrids of 2-pyridylpiperazine and 5-phenyl-1,3,4-oxadiazoles as potential multifunctional agents to treat Alzheimer\u2019s disease. Eur. J. Med. Chem. 2019;183:111707. doi: 10.1016/j.ejmech.2019.111707.", "ArticleIdList": ["10.1016/j.ejmech.2019.111707", "31561043"]}, {"Citation": "Aisen P.S., Cumming J., Jack C.R., Morris J., Sperling R., Fr\u00f6lich L., Jones R.W., Dowsett S.A., Matthews B.R., Raskin J., et al. On the path to 2025: Understanding the Alzheimer\u00b4s disease continuum. Alzheimer\u2019s Res. Ther. 2017;9:60. doi: 10.1186/s13195-017-0283-5.", "ArticleIdList": ["10.1186/s13195-017-0283-5", "PMC5549378", "28793924"]}, {"Citation": "Green K.D., Fosso M.Y., Garneu-Tsodikova S. Multifunctional donepezil analogues as cholinesterase and BACE1 inhibitors. Molecules. 2018;23:3252. doi: 10.3390/molecules23123252.", "ArticleIdList": ["10.3390/molecules23123252", "PMC6321525", "30544832"]}, {"Citation": "Viayna E., Sabate R., Mu\u00f1oz-Torrero D. Dual inhibitors of beta-amyloid aggregation and acetylcholinesterase as multi-target anti-Alzheimer drug candidates. Curr. Top. Med. Chem. 2013;13:1820\u20131842. doi: 10.2174/15680266113139990139.", "ArticleIdList": ["10.2174/15680266113139990139", "23931440"]}, {"Citation": "Selkoe D.J., Hardy J. The amyloid hypothesis of Alzheimer\u00b4s disease al 25 years. EMBO Mol. Med. 2016;8:595\u2013608. doi: 10.15252/emmm.201606210.", "ArticleIdList": ["10.15252/emmm.201606210", "PMC4888851", "27025652"]}, {"Citation": "Wei J., Wu C., Lankin D., Gulrati A., Valyi-Nagy T., Cochran E., Pike V.W., Kozikowski A., Wang Y. Development of novel amyloid imaging agent based upon thioflavin S. Curr. Alzheimer Res. 2005;2:109\u2013114. doi: 10.2174/1567205053585864.", "ArticleIdList": ["10.2174/1567205053585864", "15974905"]}, {"Citation": "Alvarez A., Alarc\u00f3n R., Opazo C., Campos E.O., Mu\u00f1oz F.J., Calderon F.H., Dajas F., Gendry M.K., Doctor B.P., de Mello F.G., et al. Stable complexes involving acetylcholinesterase and amyloid-B peptide change the biochemical properties of enzyme and increase the neurotoxicity of Alzheimer\u2019s fibrils. J. Neurosci. 1998;18:3213\u20133223. doi: 10.1523/JNEUROSCI.18-09-03213.1998.", "ArticleIdList": ["10.1523/JNEUROSCI.18-09-03213.1998", "PMC6792661", "9547230"]}, {"Citation": "Dinamarca M., Sagal J.P., Quintanilla R.A., Godoy J.A., Arrazola M.S., Inestrosa N. Amyloid-B-acetylcholinesterase complexes potentiate neurodegenerative changes induced by the AB peptide. Implication for the pathogenesis of Alzheimer\u00b4s disease. Mol. Neurodegener. 2010;5:4. doi: 10.1186/1750-1326-5-4.", "ArticleIdList": ["10.1186/1750-1326-5-4", "PMC2823746", "20205793"]}, {"Citation": "Grisaru D., Sternfeld M., Eldor A., Glick D., Soreq H. Structural roles of acetylcholinesterase variants in biology and pathology. Eur. J. Biochem. 1999;264:672\u2013686. doi: 10.1046/j.1432-1327.1999.00693.x.", "ArticleIdList": ["10.1046/j.1432-1327.1999.00693.x", "10491113"]}, {"Citation": "Johnson G., Moore S.W. Identification of a structural site on acetylcholinesterase that promotes neurite outgrowth and binds laminin-1 and collagen IV. Biochem. Biophys. Res. Commun. 2004;319:448\u2013455. doi: 10.1016/j.bbrc.2004.05.018.", "ArticleIdList": ["10.1016/j.bbrc.2004.05.018", "15178427"]}, {"Citation": "Patyar S., Prakash A., Medhi B. Dual inhibition: A novel promising pharmacological approach for different disease conditions. J. Pharm. Pharmacol. 2011;63:459\u2013471. doi: 10.1111/j.2042-7158.2010.01236.x.", "ArticleIdList": ["10.1111/j.2042-7158.2010.01236.x", "21401597"]}, {"Citation": "Benet L.Z., Hosey C.M., Ursu O., Oprea T.I. BDDCS, the rule of 5 and drugability. Adv. Drug Deliv. Rev. 2016;101:89\u201398. doi: 10.1016/j.addr.2016.05.007.", "ArticleIdList": ["10.1016/j.addr.2016.05.007", "PMC4910824", "27182629"]}, {"Citation": "Tian H., Ketkar R., Tao P. ADMETboost: A web server for accurate ADMET prediction. J. Mol. Model. 2022;28:408. doi: 10.1007/s00894-022-05373-8.", "ArticleIdList": ["10.1007/s00894-022-05373-8", "PMC9903341", "36454321"]}, {"Citation": "Bakchi B., Krishna A.D., Sreecharan E., Ganesh V.B.J., Niharika M., Maharshi S., Shaik A.B. An overview on applications of SwissADME web tool in the design and development of anticancer, antitubercular and antimicrobial agents: A medicinal chemist\u2019s perspective. J. Mol. Struct. 2022;1259:132712. doi: 10.1016/j.molstruc.2022.132712.", "ArticleIdList": ["10.1016/j.molstruc.2022.132712"]}, {"Citation": "Radchenko E.V., Karpov P.V., Sosnin S.B., Dyabina A.S., Sosnina E.A., Palyulin V.A., Zefirov N.S. Sistema para la predicci\u00f3n de propiedades farmacocin\u00e9ticas y toxicidad de compuestos farmacol\u00f3gicos; Proceedings of the XX Congreso Mendeleev Sobre Qu\u00edmica General y Aplicada; Ekaterimburgo, Russia. 26\u201330 September 2016; p. 424."}, {"Citation": "Guo H.B., Cheng Y.F., Wu J.G., Wang G.M., Wang H.T., Zhang C., Qiu Z.K., Xu J.P. Donepezil improves learning and memory deficits in APP/PS1 mice by inhibition of microalgial activation. Neuroscience. 2015;290:530\u2013542. doi: 10.1016/j.neuroscience.2015.01.058.", "ArticleIdList": ["10.1016/j.neuroscience.2015.01.058", "25662507"]}, {"Citation": "Ellman G.L., Courtney K.D., Andres V., Featherstone R.M. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem. Pharm. 1961;7:88\u201395. doi: 10.1016/0006-2952(61)90145-9.", "ArticleIdList": ["10.1016/0006-2952(61)90145-9", "13726518"]}, {"Citation": "Gerlits O., Ho K.Y., Cheng X., Blumenthal D., Taylor P., Kovalevsky A., Radi\u0107 Z. A new crystal of human acetylcholinesterase for exploratory room temperature crystallography studies. Chem.-Biol. Interact. 2019;309:108698. doi: 10.1016/j.cbi.2019.06.011.", "ArticleIdList": ["10.1016/j.cbi.2019.06.011", "PMC6679772", "31176713"]}, {"Citation": "Kryger G., Silman I., Sussman J.L. Three-dimensional structure of a complex of E2020 with acetylcholinesterase from Torpedo californica. J. Physiol. Paris. 1998;92:191\u2013194. doi: 10.1016/S0928-4257(98)80008-9.", "ArticleIdList": ["10.1016/S0928-4257(98)80008-9", "9789806"]}, {"Citation": "Morris G., Goodsell D., Halliday R., Huey R., Hart W., Belew R., Olson A. Automated docking using a Lamarckian Genetic algorithm and an empirical binding free energy function. J. Comput. Chem. 1998;19:1639\u20131662. doi: 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B.", "ArticleIdList": ["10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B"]}, {"Citation": "Daina A., Michielin O., Zoete V. SwissADME: A free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Sci. Rep. 2017;7:42717. doi: 10.1038/srep42717.", "ArticleIdList": ["10.1038/srep42717", "PMC5335600", "28256516"]}, {"Citation": "SwissADME.  [(accessed on 5 February 2024)].  Available online:  http://www.swissadme.ch."}]}], "History": [{"Year": "2024", "Month": "5", "Day": "3"}, {"Year": "2024", "Month": "6", "Day": "19"}, {"Year": "2024", "Month": "6", "Day": "24"}, {"Year": "2024", "Month": "7", "Day": "13", "Hour": "7", "Minute": "44"}, {"Year": "2024", "Month": "7", "Day": "13", "Hour": "7", "Minute": "43"}, {"Year": "2024", "Month": "7", "Day": "13", "Hour": "1", "Minute": "16"}, {"Year": "2024", "Month": "7", "Day": "3"}], "PublicationStatus": "epublish", "ArticleIdList": ["39000410", "PMC11242892", "10.3390/ijms25137303", "ijms25137303"]}}]}